Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 36 | 2017 | 501 | 3.200 |
Why?
|
| Nephrectomy | 14 | 2022 | 172 | 2.770 |
Why?
|
| Kidney Neoplasms | 13 | 2022 | 432 | 1.990 |
Why?
|
| Ureteral Obstruction | 7 | 2017 | 105 | 1.750 |
Why?
|
| Robotics | 11 | 2022 | 106 | 1.450 |
Why?
|
| Prostatectomy | 15 | 2010 | 332 | 1.290 |
Why?
|
| Carcinoma, Renal Cell | 8 | 2016 | 240 | 1.120 |
Why?
|
| Robotic Surgical Procedures | 4 | 2024 | 194 | 0.860 |
Why?
|
| Kidney Pelvis | 4 | 2014 | 43 | 0.840 |
Why?
|
| Nephrostomy, Percutaneous | 2 | 2014 | 18 | 0.840 |
Why?
|
| Para-Aortic Bodies | 1 | 2020 | 2 | 0.740 |
Why?
|
| Hemangioma | 1 | 2020 | 95 | 0.670 |
Why?
|
| Models, Anatomic | 2 | 2018 | 98 | 0.660 |
Why?
|
| Clinical Competence | 6 | 2024 | 972 | 0.620 |
Why?
|
| Kidney | 6 | 2018 | 1337 | 0.620 |
Why?
|
| Ureter | 3 | 2024 | 95 | 0.600 |
Why?
|
| Lymph Node Excision | 5 | 2006 | 157 | 0.590 |
Why?
|
| Urologic Surgical Procedures | 6 | 2024 | 58 | 0.580 |
Why?
|
| Stents | 4 | 2024 | 871 | 0.580 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2017 | 9 | 0.560 |
Why?
|
| Tomography, Emission-Computed | 1 | 2017 | 43 | 0.560 |
Why?
|
| Ureteroscopy | 2 | 2014 | 17 | 0.560 |
Why?
|
| Silicones | 1 | 2016 | 33 | 0.550 |
Why?
|
| Kidney Diseases | 3 | 2012 | 478 | 0.550 |
Why?
|
| Printing, Three-Dimensional | 1 | 2016 | 68 | 0.520 |
Why?
|
| Diuretics | 1 | 2017 | 158 | 0.520 |
Why?
|
| Simulation Training | 1 | 2018 | 139 | 0.520 |
Why?
|
| Hydrothorax | 1 | 2014 | 11 | 0.480 |
Why?
|
| Respiratory Tract Fistula | 1 | 2014 | 15 | 0.480 |
Why?
|
| Testicular Neoplasms | 2 | 2006 | 132 | 0.470 |
Why?
|
| Urinary Fistula | 1 | 2014 | 20 | 0.470 |
Why?
|
| Ureteral Neoplasms | 1 | 2014 | 24 | 0.470 |
Why?
|
| Kidney Calculi | 1 | 2014 | 40 | 0.460 |
Why?
|
| Organ Sparing Treatments | 1 | 2014 | 34 | 0.460 |
Why?
|
| Precision Medicine | 1 | 2016 | 312 | 0.440 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2020 | 2056 | 0.420 |
Why?
|
| Replantation | 2 | 2011 | 54 | 0.420 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 40 | 0.420 |
Why?
|
| Device Removal | 2 | 2013 | 222 | 0.410 |
Why?
|
| Male | 48 | 2024 | 60079 | 0.410 |
Why?
|
| Urology | 4 | 2024 | 74 | 0.410 |
Why?
|
| Living Donors | 1 | 2013 | 112 | 0.400 |
Why?
|
| Computer Simulation | 3 | 2018 | 635 | 0.400 |
Why?
|
| Middle Aged | 35 | 2017 | 25994 | 0.380 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2011 | 19 | 0.370 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 21 | 0.370 |
Why?
|
| Ureteral Calculi | 1 | 2010 | 15 | 0.370 |
Why?
|
| Nephrolithiasis | 1 | 2010 | 14 | 0.370 |
Why?
|
| Humans | 63 | 2024 | 123166 | 0.350 |
Why?
|
| Prostatic Neoplasms | 6 | 2010 | 1512 | 0.340 |
Why?
|
| Cryosurgery | 5 | 2007 | 46 | 0.340 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 770 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3543 | 0.320 |
Why?
|
| Kidney Transplantation | 2 | 2018 | 628 | 0.310 |
Why?
|
| Urethra | 1 | 2008 | 83 | 0.310 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 258 | 0.310 |
Why?
|
| Models, Animal | 3 | 2013 | 464 | 0.310 |
Why?
|
| Sus scrofa | 1 | 2008 | 122 | 0.310 |
Why?
|
| Anastomosis, Surgical | 1 | 2008 | 169 | 0.300 |
Why?
|
| Quality of Life | 8 | 2024 | 1929 | 0.300 |
Why?
|
| Adult | 25 | 2022 | 29061 | 0.300 |
Why?
|
| Incidental Findings | 2 | 2020 | 125 | 0.270 |
Why?
|
| Chylous Ascites | 1 | 2006 | 11 | 0.270 |
Why?
|
| Prostate-Specific Antigen | 2 | 2004 | 246 | 0.260 |
Why?
|
| Decision Trees | 1 | 2005 | 49 | 0.250 |
Why?
|
| Germinoma | 1 | 2005 | 31 | 0.250 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2006 | 88 | 0.250 |
Why?
|
| Aged | 19 | 2020 | 19080 | 0.240 |
Why?
|
| Intestines | 1 | 2008 | 570 | 0.240 |
Why?
|
| Penile Neoplasms | 1 | 2004 | 32 | 0.240 |
Why?
|
| Urolithiasis | 2 | 2022 | 8 | 0.230 |
Why?
|
| Uterine Prolapse | 1 | 2004 | 19 | 0.230 |
Why?
|
| Erectile Dysfunction | 5 | 2018 | 170 | 0.230 |
Why?
|
| Perineum | 1 | 2004 | 50 | 0.230 |
Why?
|
| Hypogonadism | 2 | 2018 | 249 | 0.230 |
Why?
|
| Cystectomy | 2 | 2004 | 152 | 0.230 |
Why?
|
| Hospitals, Urban | 1 | 2004 | 97 | 0.230 |
Why?
|
| Hospital Charges | 1 | 2004 | 61 | 0.230 |
Why?
|
| Blood Chemical Analysis | 1 | 2004 | 77 | 0.220 |
Why?
|
| Hospital Costs | 2 | 2005 | 178 | 0.220 |
Why?
|
| Sleep | 2 | 2016 | 345 | 0.220 |
Why?
|
| Treatment Outcome | 12 | 2014 | 12129 | 0.210 |
Why?
|
| Female | 27 | 2024 | 65499 | 0.210 |
Why?
|
| Penile Erection | 3 | 2010 | 67 | 0.210 |
Why?
|
| Postoperative Period | 3 | 2017 | 330 | 0.200 |
Why?
|
| Abdomen | 2 | 2020 | 129 | 0.200 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 271 | 0.190 |
Why?
|
| Urinary Tract | 1 | 2022 | 60 | 0.190 |
Why?
|
| Female Urogenital Diseases | 1 | 2001 | 7 | 0.190 |
Why?
|
| Male Urogenital Diseases | 1 | 2001 | 12 | 0.180 |
Why?
|
| Hemorrhage | 1 | 2004 | 459 | 0.180 |
Why?
|
| Urinary Reservoirs, Continent | 1 | 2001 | 21 | 0.180 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2020 | 12 | 0.180 |
Why?
|
| Urinary Diversion | 1 | 2001 | 40 | 0.180 |
Why?
|
| Radionuclide Imaging | 1 | 2020 | 151 | 0.180 |
Why?
|
| Follow-Up Studies | 8 | 2014 | 5047 | 0.170 |
Why?
|
| Prospective Studies | 6 | 2018 | 6033 | 0.170 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2004 | 542 | 0.170 |
Why?
|
| Lymphatic Metastasis | 4 | 2005 | 400 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 651 | 0.170 |
Why?
|
| Young Adult | 4 | 2014 | 8863 | 0.160 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 1414 | 0.160 |
Why?
|
| Counseling | 1 | 2001 | 219 | 0.160 |
Why?
|
| Retrospective Studies | 12 | 2016 | 16021 | 0.160 |
Why?
|
| Mass Screening | 1 | 2004 | 788 | 0.150 |
Why?
|
| Severity of Illness Index | 4 | 2016 | 2838 | 0.150 |
Why?
|
| Internship and Residency | 2 | 2024 | 1158 | 0.140 |
Why?
|
| Lithotripsy, Laser | 1 | 2017 | 12 | 0.140 |
Why?
|
| Radioactive Tracers | 1 | 2017 | 20 | 0.140 |
Why?
|
| Renal Elimination | 1 | 2017 | 9 | 0.140 |
Why?
|
| Patient Selection | 1 | 2001 | 685 | 0.140 |
Why?
|
| Prostate | 3 | 2009 | 421 | 0.140 |
Why?
|
| Feasibility Studies | 3 | 2016 | 751 | 0.140 |
Why?
|
| Metabolic Clearance Rate | 1 | 2017 | 142 | 0.140 |
Why?
|
| Aged, 80 and over | 8 | 2012 | 6371 | 0.140 |
Why?
|
| Microbiota | 1 | 2022 | 388 | 0.140 |
Why?
|
| Work | 1 | 2016 | 12 | 0.140 |
Why?
|
| Men's Health | 1 | 2016 | 19 | 0.140 |
Why?
|
| Shift Work Schedule | 1 | 2016 | 19 | 0.140 |
Why?
|
| Symptom Assessment | 1 | 2017 | 98 | 0.130 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 126 | 0.130 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2016 | 30 | 0.130 |
Why?
|
| Organ Transplantation | 1 | 2018 | 163 | 0.130 |
Why?
|
| Occupational Diseases | 1 | 2016 | 74 | 0.130 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2016 | 71 | 0.130 |
Why?
|
| Prostatic Hyperplasia | 1 | 2016 | 106 | 0.130 |
Why?
|
| Penis | 2 | 2008 | 97 | 0.130 |
Why?
|
| Surveys and Questionnaires | 6 | 2024 | 3666 | 0.130 |
Why?
|
| Costs and Cost Analysis | 2 | 2006 | 164 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 360 | 0.130 |
Why?
|
| Maryland | 2 | 2006 | 28 | 0.130 |
Why?
|
| Perioperative Care | 2 | 2009 | 195 | 0.120 |
Why?
|
| Blood Loss, Surgical | 3 | 2012 | 146 | 0.120 |
Why?
|
| Telemedicine | 1 | 2001 | 426 | 0.120 |
Why?
|
| Neoplasm Staging | 5 | 2006 | 1213 | 0.120 |
Why?
|
| Thoracostomy | 1 | 2014 | 26 | 0.120 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1590 | 0.120 |
Why?
|
| Sleep Wake Disorders | 1 | 2016 | 173 | 0.110 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 156 | 0.110 |
Why?
|
| Intraoperative Complications | 2 | 2006 | 175 | 0.110 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2013 | 193 | 0.110 |
Why?
|
| Students, Medical | 1 | 2018 | 361 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 2025 | 0.110 |
Why?
|
| Magnets | 1 | 2013 | 22 | 0.110 |
Why?
|
| Needles | 1 | 2013 | 51 | 0.110 |
Why?
|
| Postoperative Complications | 6 | 2014 | 3013 | 0.100 |
Why?
|
| Rare Diseases | 1 | 2014 | 185 | 0.100 |
Why?
|
| Warm Ischemia | 1 | 2012 | 15 | 0.100 |
Why?
|
| S100 Proteins | 1 | 2011 | 46 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 53 | 0.090 |
Why?
|
| Urinary Incontinence | 3 | 2008 | 69 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 424 | 0.090 |
Why?
|
| Antigens, CD34 | 1 | 2011 | 108 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2010 | 1009 | 0.090 |
Why?
|
| Radiography, Abdominal | 1 | 2010 | 47 | 0.090 |
Why?
|
| General Surgery | 1 | 2013 | 203 | 0.090 |
Why?
|
| Impotence, Vasculogenic | 1 | 2010 | 9 | 0.090 |
Why?
|
| Urinalysis | 1 | 2010 | 62 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 2830 | 0.090 |
Why?
|
| Recurrence | 1 | 2014 | 1422 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 159 | 0.080 |
Why?
|
| Liver | 2 | 2007 | 1734 | 0.080 |
Why?
|
| Calcinosis | 1 | 2010 | 170 | 0.080 |
Why?
|
| Retroperitoneal Space | 2 | 2006 | 19 | 0.080 |
Why?
|
| Lung | 2 | 2007 | 1475 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 2106 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1687 | 0.080 |
Why?
|
| Neoplasm Seeding | 2 | 2005 | 13 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2014 | 3316 | 0.080 |
Why?
|
| Intraoperative Period | 3 | 2006 | 73 | 0.080 |
Why?
|
| Urination Disorders | 1 | 2008 | 17 | 0.080 |
Why?
|
| Hemostasis, Surgical | 2 | 2004 | 37 | 0.070 |
Why?
|
| Cold Temperature | 1 | 2007 | 80 | 0.070 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2007 | 5 | 0.070 |
Why?
|
| Helium | 1 | 2007 | 10 | 0.070 |
Why?
|
| Peripheral Nerve Injuries | 2 | 2004 | 33 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2013 | 625 | 0.070 |
Why?
|
| Length of Stay | 4 | 2006 | 1284 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1877 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2010 | 467 | 0.070 |
Why?
|
| Nephrons | 1 | 2006 | 20 | 0.070 |
Why?
|
| Video-Assisted Surgery | 1 | 2006 | 5 | 0.070 |
Why?
|
| Models, Economic | 1 | 2006 | 51 | 0.070 |
Why?
|
| Body Temperature | 1 | 2007 | 110 | 0.070 |
Why?
|
| Ejaculation | 1 | 2006 | 20 | 0.070 |
Why?
|
| Orchiectomy | 1 | 2006 | 44 | 0.070 |
Why?
|
| Hernia, Inguinal | 1 | 2006 | 41 | 0.060 |
Why?
|
| Education, Medical, Continuing | 2 | 2011 | 138 | 0.060 |
Why?
|
| Postoperative Hemorrhage | 1 | 2006 | 86 | 0.060 |
Why?
|
| Aorta, Abdominal | 1 | 2006 | 120 | 0.060 |
Why?
|
| Constipation | 2 | 2004 | 113 | 0.060 |
Why?
|
| Inguinal Canal | 1 | 2004 | 11 | 0.060 |
Why?
|
| Fees, Medical | 1 | 2004 | 6 | 0.060 |
Why?
|
| Models, Econometric | 1 | 2004 | 9 | 0.060 |
Why?
|
| Cost Allocation | 1 | 2004 | 3 | 0.060 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2005 | 61 | 0.060 |
Why?
|
| Preoperative Care | 2 | 2010 | 350 | 0.060 |
Why?
|
| Peripheral Nerves | 1 | 2004 | 84 | 0.060 |
Why?
|
| Equipment Design | 3 | 2013 | 601 | 0.060 |
Why?
|
| Time Factors | 3 | 2010 | 6217 | 0.060 |
Why?
|
| Surgical Mesh | 1 | 2004 | 62 | 0.060 |
Why?
|
| Operating Rooms | 1 | 2004 | 69 | 0.060 |
Why?
|
| Catheter Ablation | 1 | 2006 | 233 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2004 | 356 | 0.060 |
Why?
|
| Suture Techniques | 1 | 2004 | 198 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2004 | 185 | 0.050 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 151 | 0.050 |
Why?
|
| Necrosis | 3 | 2007 | 204 | 0.050 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2004 | 191 | 0.050 |
Why?
|
| Urogenital System | 1 | 2022 | 34 | 0.050 |
Why?
|
| Swine | 3 | 2013 | 1155 | 0.050 |
Why?
|
| Frozen Sections | 1 | 2001 | 24 | 0.050 |
Why?
|
| Acute Disease | 1 | 2004 | 1094 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2010 | 4706 | 0.050 |
Why?
|
| Logistic Models | 3 | 2013 | 1793 | 0.050 |
Why?
|
| Pelvis | 1 | 2001 | 68 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2004 | 507 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1068 | 0.040 |
Why?
|
| Adolescent | 2 | 2014 | 19103 | 0.040 |
Why?
|
| Informed Consent | 1 | 2001 | 341 | 0.040 |
Why?
|
| Organ Size | 2 | 2009 | 412 | 0.040 |
Why?
|
| Animals | 5 | 2013 | 33746 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2022 | 779 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 993 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2001 | 548 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 1661 | 0.030 |
Why?
|
| Graft Survival | 1 | 2018 | 525 | 0.030 |
Why?
|
| Hernia, Obturator | 1 | 1975 | 4 | 0.030 |
Why?
|
| Infertility, Male | 1 | 2018 | 262 | 0.030 |
Why?
|
| Hernia | 1 | 1975 | 19 | 0.030 |
Why?
|
| Lung Transplantation | 1 | 2018 | 316 | 0.030 |
Why?
|
| Self Report | 1 | 2016 | 510 | 0.030 |
Why?
|
| United States | 2 | 2024 | 10631 | 0.030 |
Why?
|
| Risk Factors | 3 | 2016 | 10010 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 188 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2018 | 854 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2005 | 1472 | 0.020 |
Why?
|
| Alprostadil | 1 | 2010 | 27 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 120 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2018 | 1014 | 0.020 |
Why?
|
| Program Development | 1 | 2010 | 191 | 0.020 |
Why?
|
| Health Surveys | 1 | 2010 | 241 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 203 | 0.020 |
Why?
|
| Health Status | 1 | 2010 | 374 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2007 | 41 | 0.020 |
Why?
|
| Thermometers | 1 | 2007 | 11 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2007 | 87 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 1243 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 229 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 12348 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 28 | 0.020 |
Why?
|
| Prognosis | 2 | 2006 | 4507 | 0.020 |
Why?
|
| Diagnostic Techniques, Surgical | 1 | 2006 | 2 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 1259 | 0.020 |
Why?
|
| Laparoscopes | 1 | 2006 | 3 | 0.020 |
Why?
|
| Child | 2 | 2022 | 24237 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2007 | 235 | 0.020 |
Why?
|
| Age Distribution | 1 | 2006 | 410 | 0.010 |
Why?
|
| Electrosurgery | 1 | 2004 | 19 | 0.010 |
Why?
|
| Ultrasonic Therapy | 1 | 2004 | 31 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2006 | 437 | 0.010 |
Why?
|
| Genitalia, Male | 1 | 2004 | 37 | 0.010 |
Why?
|
| Dissection | 1 | 2004 | 52 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 2005 | 237 | 0.010 |
Why?
|
| Contrast Media | 1 | 2007 | 470 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2004 | 319 | 0.010 |
Why?
|
| Dogs | 1 | 2004 | 765 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 861 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 640 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 501 | 0.010 |
Why?
|
| Pain, Postoperative | 1 | 2005 | 256 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2006 | 1388 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 2802 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 1996 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2004 | 1117 | 0.010 |
Why?
|
| Nausea | 1 | 1975 | 97 | 0.010 |
Why?
|
| Intestinal Obstruction | 1 | 1975 | 97 | 0.010 |
Why?
|